Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect. “You know, maybe some ...
Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 men screened ...
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...
If it wasn’t for a chance encounter at a coffee shop in Almonte 25 years ago, Terry Cairns thinks he wouldn’t be alive today ...
CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...
Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.
Researchers report progress in looking for signs of lung cancer in the blood.
Noninvasive monitoring of low-grade prostate cancer with a urinary biomarker test could reduce the need for biopsies and serial imaging, according to a study ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
Denmaur has created a World Cup sweepstake kit to support Prostate Cancer UK and help raise awareness about the disease.
6d
Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’
A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results